Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP558331.RAnDset21IA9pSk05CSTbzEzcCyMDUFt_bicsLDsQ3ZCE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP558331.RAnDset21IA9pSk05CSTbzEzcCyMDUFt_bicsLDsQ3ZCE130_assertion type Assertion NP558331.RAnDset21IA9pSk05CSTbzEzcCyMDUFt_bicsLDsQ3ZCE130_head.
- NP558331.RAnDset21IA9pSk05CSTbzEzcCyMDUFt_bicsLDsQ3ZCE130_assertion wasGeneratedBy ECO_0000203 NP558331.RAnDset21IA9pSk05CSTbzEzcCyMDUFt_bicsLDsQ3ZCE130_provenance.
- NP558331.RAnDset21IA9pSk05CSTbzEzcCyMDUFt_bicsLDsQ3ZCE130_assertion wasDerivedFrom befree-20150227 NP558331.RAnDset21IA9pSk05CSTbzEzcCyMDUFt_bicsLDsQ3ZCE130_provenance.
- NP558331.RAnDset21IA9pSk05CSTbzEzcCyMDUFt_bicsLDsQ3ZCE130_assertion SIO_000772 17986858 NP558331.RAnDset21IA9pSk05CSTbzEzcCyMDUFt_bicsLDsQ3ZCE130_provenance.
- NP558331.RAnDset21IA9pSk05CSTbzEzcCyMDUFt_bicsLDsQ3ZCE130_assertion evidence source_evidence_literature NP558331.RAnDset21IA9pSk05CSTbzEzcCyMDUFt_bicsLDsQ3ZCE130_provenance.
- NP558331.RAnDset21IA9pSk05CSTbzEzcCyMDUFt_bicsLDsQ3ZCE130_assertion description "[Methylation of ASC/TMS1 was more common in right-sided tumors (p = 0.02), concordant with hMLH1 methylation (p = 0.03) and is a late stage event, occurring in 0 of 18 tubular adenomas, 0 of 12 villous adenomas, 2 of 44 (5%) Stage 1 cancers, 8 of 31 (26%) Stage 2 cancers, 8 of 21 (38%) Stage 3 cancers and 2 of 19 (11%) Stage 4 cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP558331.RAnDset21IA9pSk05CSTbzEzcCyMDUFt_bicsLDsQ3ZCE130_provenance.